Thursday, Oct 5, 2023 · SEC filings
What the smart money revealed on Oct 5
275 insider filings came in. We hid 42 planned (10b5-1) sellers and 145 people whose filings were routine, like grants and tax withholding.
Asana (ASAN) President Dustin Moskovitz bought $17.8M
1.01M shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 4 checked quarters beat the typical stock 6 months later.
Vaccinex (VCNX) Director Albert Friedberg bought $3M
3M shares on the open market. Not a grant or an option exercise.
Vaccinex (VCNX) President and CEO Maurice Zauderer bought $510K
510,000 shares on the open market. Not a grant or an option exercise.
Overstock.com (NXH) Director Marcus Lemonis bought $498K
31,800 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.
Samsara (IOT) Executive Vice President John Bicket sold $2.21M
Not marked as a planned 10b5-1 sale. Sold 8% of the shares they held directly. Still holds 986,789 shares.
Samsara (IOT) CEO Sanjit Biswas sold $2.2M
Not marked as a planned 10b5-1 sale. Sold 9% of the shares they held directly. Still holds 945,124 shares.
Copart (CPRT) Director Matt Blunt sold $2.13M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day.
Show 22 more real buys
Show 49 more real sales
13F season
Holdings as of Sep 30, 2023 are due Nov 14
40 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Sep 29–Oct 5
Open-market buys by officers and directors, filed in the 7 days up to Oct 5.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.